Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Dysplasia and Lichenoid Mucositis: The Chicken or the Egg?

Zhang L, Rock LD, Rosin MP, Laronde DM.

J Dent Res. 2018 Sep;97(10):1179. doi: 10.1177/0022034518782143. No abstract available.

PMID:
30096042
2.

Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.

Rock LD, Rosin MP, Zhang L, Chan B, Shariati B, Laronde DM.

Oral Oncol. 2018 Mar;78:119-125. doi: 10.1016/j.oraloncology.2018.01.028. Epub 2018 Feb 20.

3.

Using quantitative tissue phenotype to assess the margins of surgical samples from a pan-Canadian surgery study.

Guillaud M, MacAulay CE, Berean KW, Bullock M, Guggisberg K, Klieb H, Puttagunta L, Penner C, Kwan K, Rosin MP, Poh CF.

Head Neck. 2018 Jun;40(6):1263-1270. doi: 10.1002/hed.25106. Epub 2018 Feb 16.

PMID:
29451953
4.

Dysplasia Should Not Be Ignored in Lichenoid Mucositis.

Rock LD, Laronde DM, Lin I, Rosin MP, Chan B, Shariati B, Zhang L.

J Dent Res. 2018 Jul;97(7):767-772. doi: 10.1177/0022034517748639. Epub 2018 Jan 12.

5.

Optimizing Fixation Protocols to Improve Molecular Analysis from FFPE Tissues.

Maraschin BJ, Silva VP, Rock L, Sun H, Visioli F, Rados PV, Rosin MP.

Braz Dent J. 2017 Jan-Feb;28(1):82-84. doi: 10.1590/0103-6440201701211.

6.

Oral Squamous Cell Carcinomas are Associated with Poorer Outcome with Increasing Ages.

Lubpairee T, Poh CF, Laronde DM, Rosin MP, Zhang L.

J Oncol Res Ther. 2017;3(4). pii: 132. Epub 2017 Sep 25.

7.

Should severe epithelial dysplasia be treated?

Zhang L, Lubpairee T, Laronde DM, Rosin MP.

Oral Oncol. 2016 Sep;60:125-9. doi: 10.1016/j.oraloncology.2016.07.007. Epub 2016 Jul 22.

8.

Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer.

Poh CF, Anderson DW, Durham JS, Chen J, Berean KW, MacAulay CE, Rosin MP.

JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):209-16. doi: 10.1001/jamaoto.2015.3211.

PMID:
26769431
9.

Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils and Their HPV16 E6/E7-Induced Perturbation.

Kang SYC, Kannan N, Zhang L, Martinez V, Rosin MP, Eaves CJ.

Stem Cell Reports. 2015 Dec 8;5(6):1210-1225. doi: 10.1016/j.stemcr.2015.09.020. Epub 2015 Oct 29.

10.

Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities.

Martinez VD, MacAulay CE, Guillaud M, Lam WL, Zhang L, Corbett KK, Rosin MP.

Oral Oncol. 2014 Dec;50(12):1123-30. doi: 10.1016/j.oraloncology.2014.08.012. Epub 2014 Sep 16.

11.

Decision making on detection and triage of oral mucosa lesions in community dental practices: screening decisions and referral.

Laronde DM, Williams PM, Hislop TG, Poh C, Ng S, Zhang L, Rosin MP.

Community Dent Oral Epidemiol. 2014 Aug;42(4):375-84. doi: 10.1111/cdoe.12093. Epub 2014 Jan 25.

12.

Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices.

Laronde DM, Williams PM, Hislop TG, Poh C, Ng S, Bajdik C, Zhang L, MacAulay C, Rosin MP.

J Oral Pathol Med. 2014 Jan;43(1):7-13. doi: 10.1111/jop.12090. Epub 2013 Jun 10.

13.

Predicting progression of oral dysplasia--response.

Rosin MP, Zhang L, Mao L.

Cancer Prev Res (Phila). 2013 Jun;6(6):616. doi: 10.1158/1940-6207.CAPR-13-0111. Epub 2013 Apr 16. No abstract available.

14.

High throughput image cytometry for detection of suspicious lesions in the oral cavity.

Macaulay C, Poh CF, Guillaud M, Michele Williams P, Laronde DM, Zhang L, Rosin MP.

J Biomed Opt. 2012 Aug;17(8):086004-1. doi: 10.1117/1.JBO.17.8.086004.

15.

Gender- and ethnicity-specific survival trends of oral cavity and oropharyngeal cancers in British Columbia.

Auluck A, Hislop G, Bajdik C, Hay J, Bottorff JL, Zhang L, Rosin MP.

Cancer Causes Control. 2012 Dec;23(12):1899-909. doi: 10.1007/s10552-012-0065-0. Epub 2012 Sep 28.

PMID:
23053792
16.

Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.

Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, Jiang H, Wu L, Lee JJ, Rosin MP.

Cancer Prev Res (Phila). 2012 Sep;5(9):1081-9. doi: 10.1158/1940-6207.CAPR-12-0173. Epub 2012 Aug 21.

17.

Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trial.

Poh CF, Durham JS, Brasher PM, Anderson DW, Berean KW, MacAulay CE, Lee JJ, Rosin MP.

BMC Cancer. 2011 Oct 25;11:462. doi: 10.1186/1471-2407-11-462.

18.

Unique FISH patterns associated with cancer progression of oral dysplasia.

Poh CF, Zhu Y, Chen E, Berean KW, Wu L, Zhang L, Rosin MP.

J Dent Res. 2012 Jan;91(1):52-7. doi: 10.1177/0022034511425676. Epub 2011 Oct 11.

19.

Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions.

Gibb EA, Enfield KS, Stewart GL, Lonergan KM, Chari R, Ng RT, Zhang L, MacAulay CE, Rosin MP, Lam WL.

Oral Oncol. 2011 Nov;47(11):1055-61. doi: 10.1016/j.oraloncology.2011.07.008. Epub 2011 Aug 10.

PMID:
21835683
20.

Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era.

Poh CF, MacAulay CE, Laronde DM, Williams PM, Zhang L, Rosin MP.

Periodontol 2000. 2011 Oct;57(1):73-88. doi: 10.1111/j.1600-0757.2011.00386.x. Review. No abstract available.

21.

The epidermal growth factor receptor axis: support for a new target for oral premalignancy.

Rosin MP, Califano JA.

Cancer Prev Res (Phila). 2010 Jul;3(7):797-9. doi: 10.1158/1940-6207.CAPR-10-0114. Epub 2010 Jun 22.

22.

Genomic imbalances in precancerous tissues signal oral cancer risk.

Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, Lam WL.

Mol Cancer. 2009 Jul 23;8:50. doi: 10.1186/1476-4598-8-50.

23.

Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L, Lam WL.

Int J Cancer. 2009 Nov 1;125(9):2219-28. doi: 10.1002/ijc.24611.

24.

Areca nut and betel quid chewing among South Asian immigrants to Western countries and its implications for oral cancer screening.

Auluck A, Hislop G, Poh C, Zhang L, Rosin MP.

Rural Remote Health. 2009 Apr-Jun;9(2):1118. Epub 2009 May 14.

25.

Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact.

Poh CF, MacAulay CE, Zhang L, Rosin MP.

Cancer Prev Res (Phila). 2009 May;2(5):401-4. doi: 10.1158/1940-6207.CAPR-09-0060. Epub 2009 Apr 28. Review. No abstract available.

26.

Multiple aberrations of chromosome 3p detected in oral premalignant lesions.

Tsui IF, Rosin MP, Zhang L, Ng RT, Lam WL.

Cancer Prev Res (Phila). 2008 Nov;1(6):424-9. doi: 10.1158/1940-6207.CAPR-08-0123.

27.

Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.

Auluck A, Rosin MP, Zhang L, Sumanth KN.

J Can Dent Assoc. 2008 Oct;74(8):735-40. Review.

28.

Primary malignant melanoma of maxillary gingiva--a case report and review of the literature.

Auluck A, Zhang L, Desai R, Rosin MP.

J Can Dent Assoc. 2008 May;74(4):367-71. Review.

29.

Oral cancer awareness among immigrant Indo-Canadian community of Vancouver, BC.

Auluck A, Rosin MP, Hislop G.

Rural Remote Health. 2008 Apr-Jun;8(2):1004. Epub 2008 May 7. No abstract available.

30.

Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.

Guillaud M, Zhang L, Poh C, Rosin MP, MacAulay C.

Cancer Res. 2008 May 1;68(9):3099-107. doi: 10.1158/0008-5472.CAN-07-2113.

31.

Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions.

Poh CF, Ng S, Berean KW, Williams PM, Rosin MP, Zhang L.

J Can Dent Assoc. 2008 Apr;74(3):283-8.

32.

Evaluation of a suspicious oral mucosal lesion.

Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP.

J Can Dent Assoc. 2008 Apr;74(3):275-80.

33.

Oral cancer: just the facts.

Laronde DM, Hislop TG, Elwood JM, Rosin MP.

J Can Dent Assoc. 2008 Apr;74(3):269-72.

34.

New hope for an oral cancer solution: together we can make a difference.

Rosin MP, Poh CF, Elwood JM, Williams PM, Gallagher R, MacAulay C, Lam WW, Auluck A, Zhang L, Hislop TG.

J Can Dent Assoc. 2008 Apr;74(3):261-6.

35.

Why should dentists screen for oral cancer?

Musa Z, Johnston K, Peacock S, Rosin MP, Elwood JM.

J Can Dent Assoc. 2008 Apr;74(3):243-4. No abstract available.

36.

Voices from the community--experiences from the dental office: initiating oral cancer screening.

Laronde DM, Bottorff JL, Hislop TG, Poh CY, Currie B, Williams PM, Rosin MP.

J Can Dent Assoc. 2008 Apr;74(3):239-41. No abstract available.

37.

Oral cancer screening in a high-risk underserved community--Vancouver Downtown Eastside.

Poh CF, Hislop G, Currie B, Lee R, Sikorski S, Zed C, Zhang L, Macaulay C, Rosin MP.

J Health Care Poor Underserved. 2007 Nov;18(4):767-78.

PMID:
17982206
38.

A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program.

Laronde DM, Poh CF, Williams PM, Hislop TG, Zhang L, MacAulay C, Rosin MP.

J Can Dent Assoc. 2007 Sep;73(7):607-9. No abstract available.

39.

Visualization and other emerging technologies as change makers for oral cancer prevention.

Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacaUlay C.

Ann N Y Acad Sci. 2007 Mar;1098:167-83. Epub 2007 Mar 1. Review.

PMID:
17332080
40.

Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients.

Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, Berean KW, Ng S, Tseng OL, MacAulay C, Rosin MP.

Clin Cancer Res. 2006 Nov 15;12(22):6716-22.

41.

Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device.

Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP.

Head Neck. 2007 Jan;29(1):71-6.

PMID:
16983693
42.

Heads up! - a call for dentists to screen for oral cancer.

Poh CF, Williams PM, Zhang L, Rosin MP.

J Can Dent Assoc. 2006 Jun;72(5):413-6. No abstract available.

43.

Simple device for the direct visualization of oral-cavity tissue fluorescence.

Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin MP, MacAulay CE.

J Biomed Opt. 2006 Mar-Apr;11(2):024006.

44.

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.

Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP.

Cancer Res. 2005 Sep 1;65(17):8017-21.

45.

Multiple microalterations detected at high frequency in oral cancer.

Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL.

Cancer Res. 2005 Sep 1;65(17):7561-7.

46.

Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis.

Garnis C, Rosin MP, Zhang L, Lam WL.

Int J Cancer. 2005 Sep 20;116(5):813-9.

47.

OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis.

Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL.

Oral Oncol. 2004 May;40(5):511-9.

PMID:
15006624
48.
49.
50.

Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer.

Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL.

Genes Chromosomes Cancer. 2004 Jan;39(1):93-8.

PMID:
14603447

Supplemental Content

Loading ...
Support Center